John Killmer - American Vanguard Lead Independent Director
| AVD Stock | USD 5.14 0.06 1.15% |
Director
Dr. John L. Killmer Ph.D., is Independent Director of American Vanguard Corporationration Mr. Killmer was elected as the Companys lead independent director and continues to serve in that capacity. During his career, Mr. Killmer was responsible for Global Marketing, Product and Supply Chain Management for Arysta LifeSciences Corporation, a large privately held crop protection and life science company, from November 2004 through June 2008. At Arysta, Mr. Killmer had global responsibility for marketing and product management and, in addition, was responsible for global supply chain management. From 1980 to 2004 he served in various capacities with Monsanto Company including three years as President of Monsanto, Greater China from 2001 to 2003. Since December 2014, Mr. Killmer has served as a member of the board of directors of APSE, Inc., a privatelyheld corporation involved in the development of RNAi technology. Mr. Killmer possesses a combination of considerable technical expertise and business acumen. A trained scientist, Mr. Killmer began his professional career focusing on technology and ascended the corporate ladder with increasing profit responsibility. He served as protem Director of Technology for the Company from March 2009 through December, 2010, during which time he evaluated the Companys technology infrastructure and added multiple resources to help enhance the Companys domestic manufacturing and process and formulation technology. since 2019.
| Age | 70 |
| Tenure | 6 years |
| Address | 4695 MacArthur Court, Newport Beach, CA, United States, 92660 |
| Phone | 949 260 1200 |
| Web | https://www.american-vanguard.com |
American Vanguard Management Efficiency
As of March 1, 2025, Return On Tangible Assets is expected to decline to 0.02. In addition to that, Return On Capital Employed is expected to decline to 0.05. At present, American Vanguard's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 521.7 M, whereas Other Current Assets are forecasted to decline to about 5.8 M. American Vanguard's management efficiency ratios could be used to measure how well American Vanguard manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Paul Norris | FMC Corporation | 73 | |
| Andrew Langham | CVR Partners LP | 46 | |
| Aviad Kaufman | ICL Israel Chemicals | 50 | |
| Jonathan Frates | CVR Partners LP | 37 | |
| Frank Muller | CVR Partners LP | 77 | |
| KLynne Johnson | FMC Corporation | 52 | |
| Avisar Paz | ICL Israel Chemicals | 64 | |
| Ruth Ralbag | ICL Israel Chemicals | 59 | |
| William Davisson | CF Industries Holdings | 72 | |
| Curt Brooks | FMC Corporation | N/A | |
| Reem Aminoach | ICL Israel Chemicals | 59 | |
| Emery Koenig | The Mosaic | 64 | |
| Robert Pallash | FMC Corporation | 69 | |
| Timothy Gitzel | The Mosaic | 57 | |
| Theresa Wagler | CF Industries Holdings | 50 | |
| Javed Ahmed | CF Industries Holdings | 61 | |
| William Powell | FMC Corporation | 73 | |
| Nancy Cooper | The Mosaic | 66 | |
| Shahid Saleem | FMC Corporation | N/A | |
| Robert Arzbaecher | CF Industries Holdings | 61 | |
| Chris Elliott | Intrepid Potash | 55 | |
Management Performance
| Return On Equity | -0.0843 | ||||
| Return On Asset | -0.0023 |
American Vanguard Leadership Team
Elected by the shareholders, the American Vanguard's board of directors comprises two types of representatives: American Vanguard inside directors who are chosen from within the company, and outside directors, selected externally and held independent of American. The board's role is to monitor American Vanguard's management team and ensure that shareholders' interests are well served. American Vanguard's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, American Vanguard's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Kuser, Director of Investor Relations | ||
| Timothy Esq, Chief Counsel | ||
| Alfred Ingulli, Independent Director | ||
| James Thompson, Portfolio Development | ||
| John Killmer, Lead Independent Director | ||
| Debra Edwards, Independent Director | ||
| Timothy Donnelly, Chief Administrative Officer, General Counsel, Secretary | ||
| David CFA, CFO VP | ||
| Emer Gunter, Independent Director | ||
| Shirin Khosravi, Senior Resources | ||
| M Zirakparvar, Independent Director | ||
| Donald Gualdoni, Chief Officer | ||
| Morton Erlich, Independent Director | ||
| Eric Wintemute, Chairman of the Board, Chief Executive Officer | ||
| Ulrich Trogele, Chief Operating Officer and Executive Vice President of AMVAC Chemical Corporation | ||
| David Johnson, Chief Financial Officer, Vice President, Treasurer | ||
| Andrew Naughton, VP Technology | ||
| Douglas CPA, Chief Officer | ||
| Peter Eilers, Managing Director, Amvac Netherlands BV | ||
| Robert Gilbane, President Inc | ||
| Lawrence Clark, Independent Director | ||
| Scott Baskin, Independent Director | ||
| Anthony Hendrix, Senior Vice President - Crop Sales for U.S. & Canada | ||
| Marisol Angelini, Director |
American Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is American Vanguard a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0843 | ||||
| Return On Asset | -0.0023 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.17) % | ||||
| Current Valuation | 338.74 M | ||||
| Shares Outstanding | 28.79 M | ||||
| Shares Owned By Insiders | 9.31 % | ||||
| Shares Owned By Institutions | 74.55 % | ||||
| Number Of Shares Shorted | 1.06 M | ||||
| Price To Earning | 44.20 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether American Vanguard is a strong investment it is important to analyze American Vanguard's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact American Vanguard's future performance. For an informed investment choice regarding American Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Vanguard. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade American Stock refer to our How to Trade American Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Vanguard. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Vanguard listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Dividend Share 0.03 | Earnings Share (1.04) | Revenue Per Share | Quarterly Revenue Growth (0.21) |
The market value of American Vanguard is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Vanguard's value that differs from its market value or its book value, called intrinsic value, which is American Vanguard's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Vanguard's market value can be influenced by many factors that don't directly affect American Vanguard's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between American Vanguard's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Vanguard is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Vanguard's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.